IFP Advisors Inc Sells 28,861 Shares of Bath & Body Works, Inc. $BBWI

IFP Advisors Inc trimmed its stake in Bath & Body Works, Inc. (NYSE:BBWI) by 83.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,686 shares of the company’s stock after selling 28,861 shares during the period. IFP Advisors Inc’s holdings in Bath & Body Works were worth $114,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Royal Bank of Canada raised its position in shares of Bath & Body Works by 92.8% during the 1st quarter. Royal Bank of Canada now owns 59,877 shares of the company’s stock valued at $1,815,000 after buying an additional 28,815 shares in the last quarter. Goldman Sachs Group Inc. raised its position in shares of Bath & Body Works by 15.7% during the 1st quarter. Goldman Sachs Group Inc. now owns 645,970 shares of the company’s stock valued at $19,586,000 after buying an additional 87,529 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Bath & Body Works by 7.0% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 562,757 shares of the company’s stock valued at $17,063,000 after buying an additional 36,684 shares in the last quarter. Intech Investment Management LLC purchased a new stake in shares of Bath & Body Works during the 1st quarter valued at $1,155,000. Finally, Geneos Wealth Management Inc. raised its position in shares of Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after buying an additional 801 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors.

Bath & Body Works Price Performance

Shares of BBWI stock opened at $19.98 on Friday. The stock has a market capitalization of $4.03 billion, a PE ratio of 5.61, a P/E/G ratio of 2.00 and a beta of 1.43. Bath & Body Works, Inc. has a 1-year low of $14.27 and a 1-year high of $33.96. The business has a 50-day moving average of $18.65 and a 200 day moving average of $20.22.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.03. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The business had revenue of $1.38 billion for the quarter, compared to analysts’ expectations of $1.36 billion. During the same period in the previous year, the firm earned $0.49 EPS. The business’s quarterly revenue was down 3.2% on a year-over-year basis. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Analysts anticipate that Bath & Body Works, Inc. will post 2.6 EPS for the current year.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, June 19th. Stockholders of record on Friday, June 5th will be issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.0%. The ex-dividend date is Friday, June 5th. Bath & Body Works’s dividend payout ratio is currently 22.47%.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on BBWI shares. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Bath & Body Works in a research note on Monday, April 20th. Barclays dropped their price target on Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating for the company in a research note on Thursday. Piper Sandler assumed coverage on Bath & Body Works in a research note on Friday, May 15th. They set a “neutral” rating and a $20.00 price target for the company. The Goldman Sachs Group cut their target price on Bath & Body Works from $26.00 to $23.00 and set a “neutral” rating for the company in a research note on Thursday. Finally, UBS Group reduced their price target on shares of Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 20th. Three investment analysts have rated the stock with a Buy rating and fifteen have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $21.93.

More Bath & Body Works News

Here are the key news stories impacting Bath & Body Works this week:

• Positive Sentiment: Bath & Body Works beat Q1 estimates, with sales and earnings coming in ahead of Wall Street expectations; investors are also encouraged by management’s upbeat outlook for growth momentum over the next two years. Reuters: Bath & Body Works beats quarterly estimates on strong demand for ‘affordable luxury’
• Positive Sentiment: TD Cowen raised its price target on BBWI to $25 and reiterated a buy rating, signaling confidence in further upside from current levels. Tickerreport.com: Bath & Body Works price target raised by TD Cowen
• Positive Sentiment: Recent coverage highlights that investors are focusing on valuation, dividend appeal, and potential Amazon-related growth opportunities, which may be helping support the rally. MarketBeat: Bath & Body Works Stock Surged Despite Falling Sales—Here’s Why
• Neutral Sentiment: Wells Fargo, Telsey Advisory Group, and Goldman Sachs all trimmed their price targets, but maintained ratings that range from overweight to neutral, suggesting analysts still see value even as they moderate expectations. The Fly: analyst target changes
• Neutral Sentiment: Brokerage consensus remains at “Hold,” indicating the market is still waiting for proof that the earnings beat can translate into sustained growth. American Banking News: Bath & Body Works receives consensus recommendation of Hold

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.